Physician profile
Timothy Collins
NPI 1760586903
$4,610.95
in general payments reported to CMS, 2019-2025
15 companies · $758 in 2025
The $758 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2021: $522 · 2022: $2,600 · 2023: $129 · 2024: $273 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $2,475.22 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $602.25 | 2021-2025 | |
| Genzyme Corporation | $249.98 | 2024-2025 | |
| Insmed, INC. | $220.58 | 2019-2025 | Arikayce, Brinsupri |
| Inari Medical, INC. | $129.25 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $125.00 | 2024 | Ekosonic |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $124.96 | 2021 | |
| Abiomed | $112.73 | 2025 | |
| Olympus America INC. | $109.75 | 2019 | |
| Abbott Laboratories | $101.62 | 2019 | |
| Medtronic, INC. | $69.00 | 2025 | |
| Grifols USA, LLC | $22.71 | 2024 | Prolastin-C Liquid |
| United Therapeutics Corporation | $17.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.